Iqvia Holdings [IQV] vs Idexx Laboratories [IDXX] Detailed Stock Comparison

Iqvia Holdings Inc.

NYSE
Loading...

Idexx Laboratories, Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Iqvia Holdings Inc. wins in 10 metrics, Idexx Laboratories, Inc. wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

Metric Iqvia Holdings Inc. Idexx Laboratories, Inc. Better
P/E Ratio (TTM) 22.38 42.92 Iqvia Holdings Inc.
Price-to-Book Ratio 4.57 27.85 Iqvia Holdings Inc.
Debt-to-Equity Ratio 245.93 60.83 Idexx Laboratories, Inc.
PEG Ratio 0.94 2.41 Iqvia Holdings Inc.
EV/EBITDA 14.98 31.12 Iqvia Holdings Inc.
Profit Margin (TTM) 8.34% 24.62% Idexx Laboratories, Inc.
Operating Margin (TTM) 15.17% 29.76% Idexx Laboratories, Inc.
EBITDA Margin (TTM) 15.17% 29.76% Idexx Laboratories, Inc.
Return on Equity 21.44% 66.20% Idexx Laboratories, Inc.
Return on Assets (TTM) 5.05% 25.59% Idexx Laboratories, Inc.
Free Cash Flow (TTM) $2.05B $1.04B Iqvia Holdings Inc.
1-Year Return 15.66% 7.30% Iqvia Holdings Inc.
Price-to-Sales Ratio (TTM) 1.82 10.38 Iqvia Holdings Inc.
Enterprise Value $44.02B $46.85B Idexx Laboratories, Inc.
EV/Revenue Ratio 2.70 10.89 Iqvia Holdings Inc.
Gross Profit Margin (TTM) 32.91% 60.35% Idexx Laboratories, Inc.
Revenue per Share (TTM) $95 $54 Iqvia Holdings Inc.
Earnings per Share (Diluted) $7.83 $13.07 Idexx Laboratories, Inc.
Beta (Stock Volatility) 1.39 1.72 Iqvia Holdings Inc.
Short % of Float 3.11% 2.74% Idexx Laboratories, Inc.

Iqvia Holdings Inc. vs Idexx Laboratories, Inc. Stock Performance Analysis

Loading Price Chart...

IQV
IDXX

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Iqvia Holdings Inc.-1.69%-2.89%5.48%8.19%-20.23%-20.85%
Idexx Laboratories, Inc.1.63%1.57%7.79%-2.79%-18.64%-14.92%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Iqvia Holdings Inc.15.66%-16.00%-24.28%186.21%328.07%328.07%
Idexx Laboratories, Inc.7.30%16.12%-6.68%539.84%1,431.62%2,795.61%

Performance & Financial Health Analysis: Iqvia Holdings Inc. vs Idexx Laboratories, Inc.

MetricIQVIDXX
Market Information
Market Cap i$27.27B$44.66B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i1,429,167480,502
90 Day Avg. Volume i1,434,752516,114
Last Close$178.39$570.00
52 Week Range$153.01 - $247.05$506.91 - $769.98
% from 52W High-27.79%-25.97%
All-Time High$285.61 (Dec 27, 2021)$769.98 (Nov 26, 2025)
% from All-Time High-37.54%-25.97%
Growth Metrics
Quarterly Revenue Growth0.10%0.14%
Quarterly Earnings Growth0.18%0.15%
Financial Health
Profit Margin (TTM) i0.08%0.25%
Operating Margin (TTM) i0.15%0.30%
Return on Equity (TTM) i0.21%0.66%
Debt to Equity (MRQ) i245.9360.83
Cash & Liquidity
Book Value per Share (MRQ)$38.34$20.14
Cash per Share (MRQ)$12.62$2.26
Operating Cash Flow (TTM) i$2.65B$1.18B
Levered Free Cash Flow (TTM) i$2.22B$790.74M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Iqvia Holdings Inc. vs Idexx Laboratories, Inc.

MetricIQV (Apr 24, 2026)IDXX (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i22.3842.92
Forward P/E i12.4434.19
PEG Ratio i0.942.41
Price to Sales (TTM) i1.8210.38
Price to Book (MRQ) i4.5727.85
Market Capitalization
Market Capitalization i$27.27B$44.66B
Enterprise Value i$44.02B$46.85B
Enterprise Value Metrics
Enterprise to Revenue i2.7010.89
Enterprise to EBITDA i14.9831.12
Risk & Other Metrics
Beta i1.391.72
Book Value per Share (MRQ) i$38.34$20.14

Financial Statements Comparison: Iqvia Holdings Inc. vs Idexx Laboratories, Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricIQV (2025)IDXX (2025)
Revenue/Sales i16.31B4.30B
Cost of Goods Sold i10.88B1.64B
COGS % of Revenue i66.7%38.2%
Gross Profit i5.43B2.66B
Gross Margin i33.3%61.8%
Research & Development iN/A251.21M
Operating Income (EBIT) i2.29B1.36B
Operating Margin i14.0%31.6%
EBITDA i3.58B1.51B
EBITDA Margin i21.9%35.0%
Pre-Tax Income i1.59B1.32B
Pre-Tax Income % of Revenue i9.8%30.8%
Income Tax i252.00M264.73M
Income Tax % of Revenue i1.5%6.2%
Net Income (Profit) i1.36B1.06B
Profit Margin i8.3%24.6%

Balance Sheet & Liquidity Metrics

MetricIQV (2025)IDXX (2025)
Cash & Equivalents i1.98B180.07M
Total Current Assets i6.25B1.41B
Total Current Assets % of Revenue i38.3%32.9%
Total Current Liabilities i8.34B1.15B
Total Current Liabilities % of Revenue i51.1%26.7%
Long-Term Debt i14.11B475.99M
Long-Term Debt % of Revenue i86.5%11.1%
Total Shareholders Equity i6.63B1.61B
Retained Earnings i7.43B6.39B
Retained Earnings % of Revenue i45.5%148.5%
Property, Plant & Equipment i1.58B123.23M

Cash Flow Statement Comparison

MetricIQV (2025)IDXX (2025)
Operating Cash Flow i2.80B1.17B
Operating Cash Flow % of Revenue i17.2%27.3%
Capital Expenditures i-528.00M-124.68M
Free Cash Flow i2.05B1.04B
FCF Margin i12.6%24.2%
Debt Repayment i-8.59B-428.39M
Common Stock Repurchase i-1.24B-1.22B

Short Interest & Institutional Ownership Analysis

MetricIQVIDXX
Shares Short i4.51M1.91M
Short Ratio i2.813.85
Short % of Float i3.11%2.74%
Shares Outstanding i169.60M79.71M
Float Shares i161.25M78.75M
% Held by Insiders i1.09%0.71%
% Held by Institutions i103.10%96.04%
% Held by Public i-4.19%3.25%

Dividend Analysis & Yield Comparison: Iqvia Holdings Inc. vs Idexx Laboratories, Inc.

MetricIQVIDXX
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A